|
血小板源性生长因子受体基因重排的研究 |
| |
nbsp;leukemia[J]. J Blood, 2001,98:25182522.
[13] FIEDLER W, SERVE H, DHNER H, et al. A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease[J].J Blood, 2005, 105(3): 986993.
[14] JENNIFER A, CAINJAY L, GRISOLANO A, et a1.Complete remission of TELPDGFRB–induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657[J]. J Blood, 2004,104:561564.
[15] PIETRAS K,SJOBLOM T,RUBIN K,et a1.PDGF receptors as cancer drug targets[J].Cancer Cell,2003,3:439443.
上一页 [1] [2] [3] [4] [5] [6]
上一个医学论文： 腔静脉滤器保护下介入治疗深静脉血栓形成
下一个医学论文： 自发性脑出血患者血清MMP 9及TIMP 1水平的研究
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文